Sally Black, PhD

Head of Biology

Orexia Therapeutics

Sarah (Sally) Wurts Black, PhD, joined Orexia Therapeutics in February 2019 and serves as the Head of Biology.

Sally brings over ten years of experience in preclinical narcolepsy research through consulting at Jazz Pharmaceuticals, PLC, leading the in vivo biology department at Reset Therapeutics, Inc., and as a principal investigator at SRI International for projects sponsored by pharmaceutical companies and the National Institutes of Health.

Sally earned her PhD in Neuroscience from the University of California, Los Angeles, USA, prior to her postdoctoral training in the laboratories of Emmanuel Mignot, MD, PhD, at Stanford University and Thomas Kilduff, PhD, at SRI International.

Read more here about Orexia Therapeutics

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser